All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
CHICAGO – A study to assess the accuracy of using liquid biopsies to determine cancer mutations or biomarkers, and thereby assist in treatment decisions, helped to identify approved therapies for 49 percent of the more than 15,000 patients who participated.